AN ASSESSMENT OF THE EFFICACY OF ATORVASTATIN IN ACHIEVING LDL CHOLESTEROL TARGET LEVELS IN PATIENTS WITH CORONARY HEART DISEASE: A GENERAL PRACTICE STUDY

Adherence to evidence-based guidelines for the secondary prevention of coronary heart disease (CHD) has been shown to be poor in a number of surveys. In this open-label, non-comparative 17-week trial, 399 patients with existing CHD and LDL cholesterol concentration > 3.4 mmol/l (130 mg/dl) were treated with atorvastatin 10 mg daily. After 5 weeks, the dose of atorvastatin was adjusted according to a patient's LDL cholesterol level. Of the 379...